TGP Cinnarizine Tablet 25 mg
________________________________________
DESCRIPTION
TGP Cinnarizine Tablet 25 mg contains cinnarizine, an antihistamine with calcium channel blocking and antivertigo properties. It works by reducing stimulation of the vestibular system in the inner ear and improving blood flow, thereby helping to control balance disorders and prevent motion related symptoms.
________________________________________
USES
• Treatment of vertigo of vestibular origin
• Management of Ménière’s disease
• Relief of dizziness, tinnitus, nausea, and vomiting associated with balance disorders
• Prevention and treatment of motion sickness (travel sickness)
________________________________________
DOSAGE
• Adults (Vertigo): Usually 25 mg taken 2–3 times daily, as directed by a healthcare professional
• Motion sickness: Typically 25 mg taken 2 hours before travel, then 25 mg every 8 hours if required
Note: Dosage and duration depend on the condition being treated. Follow the physician’s instructions strictly.
________________________________________
PRECAUTIONS
• May cause drowsiness; avoid driving or operating machinery if affected
• Use with caution in patients with Parkinson’s disease
• Use with caution in patients with liver impairment
• Avoid alcohol, as it may enhance sedative effects
• Prolonged use should be monitored, especially in the elderly
• Pregnancy and breastfeeding: use only if prescribed by a healthcare professional
________________________________________
SIDE EFFECTS
• Drowsiness or sedation
• Dry mouth
• Weight gain (with long term use)
• Dizziness
• Gastrointestinal discomfort
• Rarely, tremors or worsening of Parkinsonian symptoms with prolonged use
Consult a healthcare professional if side effects persist or worsen.
________________________________________
STORAGE
• Store below 30 °C
• Keep in a dry place, protected from light and moisture
• Keep out of reach of children